A carregar...
Risk of using hydroxychloroquine as a treatment of COVID-19
The emerging COVID-19 pandemic poses a threat to the global health care system. Given the lack of antiviral therapies or vaccines for the disease, the antimalarial drug hydroxychloroquine (HCQ) obtained much attention as a treatment for COVID-19. However, there are limited and uncertain clinical dat...
Na minha lista:
| Publicado no: | Int J Risk Saf Med |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
IOS Press
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504983/ https://ncbi.nlm.nih.gov/pubmed/32474476 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JRS-200024 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|